CNB Bank’s Takeda Pharmaceutical TAK Stock Holding History

CNB Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-140	Closed	-$1.99K	–	530
2024 Q3	$1.99K	Hold	140	–	–	﹤0.01%	478
2024 Q2	$1.81K	Hold	140	–	–	﹤0.01%	479
2024 Q1	$1.95K	Hold	140	–	–	﹤0.01%	462
2023 Q4	$2K	Hold	140	–	–	﹤0.01%	446
2023 Q3	$2.17K	Hold	140	–	–	﹤0.01%	450
2023 Q2	$2.2K	Hold	140	–	–	﹤0.01%	406
2023 Q1	$2.31K	Hold	140	–	–	﹤0.01%	434
2022 Q4	$2.18K	Hold	140	–	–	﹤0.01%	408
2022 Q3	$2K	Hold	140	–	–	﹤0.01%	430
2022 Q2	$2K	Hold	140	–	–	﹤0.01%	428
2022 Q1	$2K	Hold	140	–	–	﹤0.01%	452
2021 Q4	$2K	Hold	140	–	–	﹤0.01%	432
2021 Q3	$2K	Hold	140	–	–	﹤0.01%	390
2021 Q2	$2K	Hold	140	–	–	﹤0.01%	387
2021 Q1	$3K	Hold	140	–	–	﹤0.01%	367
2020 Q4	$3K	Buy	+140	New	+$2.46K	﹤0.01%	371

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CNB Bank's TAK Position: Q4 2024 in Review

CNB Bank sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 140 shares — an estimated $1.99K sold.

CNB Bank first reported a position in TAK in Q4 2020 and held it in 16 quarters. The position peaked at $3K in Q1 2021. 301 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

CNB Bank reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
CNB Bank sold 140 Takeda Pharmaceutical shares in Q4 2024, an estimated $1.99K.
CNB Bank first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 16 quarters.
CNB Bank's Takeda Pharmaceutical position peaked at $3K in Q1 2021.
301 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on CNB Bank's 13F filing for Q4 2024, filed 15 Jan 2025.